Biotech Value Stocks Climb Out of Their Sick Bed

Nederland Nieuws Nieuws

Biotech Value Stocks Climb Out of Their Sick Bed
Nederland Laatste Nieuws,Nederland Headlines

Heard on the Street: Recent good news from Biogen and Bristol-Myers Squibb bolsters hope that years of weak performance may be ending

The biotechnology universe is divided into two groups.

The majority are companies without profits, or even sales, chasing a scientific breakthrough and the resulting massive payoff for investors. A much smaller group of companies have graduated to megacap status. Like most companies of their size, these sport massive profits and cash flows, with much less growth potential.

 

No, you are correct🧡

I guess that could happen))😀

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Berkshire Hathaway’s Quarterly Earnings Fell as Unrealized Investment Gains DeclinedBerkshire Hathaway’s Quarterly Earnings Fell as Unrealized Investment Gains DeclinedWarren Buffett’s Berkshire Hathaway said third-quarter earnings fell as unrealized investment gains declined but operating earnings climbed In other words...he made money. Bail! There are plenty of other choices. It's a pity, but no better idea.
Lees verder »



Render Time: 2025-01-10 07:26:57